Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes
Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients…
Metabolic Disorders
-
-
Western Sydney University team develops AI tool for type 1 diabetes
A research team led by Western Sydney University in Australia has developed an AI-powered tool that could evaluate the development…
-
Abbott’s studies show CGM technology linked to lower heart hospitalisation risk
Abbott's REFLECT real-world retrospective studies indicate that FreeStyle Libre continuous glucose monitoring (CGM) technology use is linked to a significant…
-
Glucotrack gains HREC approval for clinical study of CBGM device
Glucotrack has announced the receipt of St Vincent’s Hospital Melbourne Human Research Ethics Committee’s (HREC) approval for a multi-centre clinical…
-
Vivani treats first patient with long-lasting drug implant for weight loss
A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the…
-
Proteomics announces Australian launch of predictive diabetic kidney test
Proteomics International Laboratories has launched the PromarkerD diabetic kidney disease (DKD) predictive test in Australia. The test is said to…
-
FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes
The US Food and Drug Administration (FDA) has cleared Tandem Diabetes Care’s Control-IQ+ technology, an automated insulin delivery algorithm, for use…
-
Allurion’s weight loss balloon back on French market
Seven months after suspending sales of its weight loss balloon in France due to safety concerns, Allurion’s products are back…
-
Allurion shares soar 77% after sharing plans for GLP-1RA combo trial
If you can’t beat them then join them. In a bid to combat weakening financial performance, Allurion has revealed plans…
-
Sequana shares surge after FDA approval for alfapump
The US Food and Drug Administration (FDA) has approved Sequana Medical’s alfapump for the treatment of recurrent or refractory ascites…
